AI Signal & Stock Analysis · Strong ↑
As of Aug 14 2026, 1:04 PM, AkshayaAI's signal for APGE is Strong ↑; the stock is at $134.56 (+0.08% today); overbought (RSI 76); technical trend is down-trend; news sentiment is nan.
Data as of Aug 14 2026, 1:04 PM. Informational analytics only — not investment advice.
| AI signal (Strength) | Strong ↑ |
|---|---|
| Price | $134.56 |
| Change today | +0.08% |
| RSI (14) | 76.27 |
| Relative volume | 0.44 |
| Composite (RMTPGV) score | 🔒 members |
| Market cap | $10.2B |
| Forward P/E | 0.00 |
| 52-week high | -0.2% away |
| 52-week low | +280.2% above |
| Technical trend | Down-trend (since 2026-05-27) |
| News sentiment | Nan |
| Sector | Healthcare-Genetherapy |
| Next earnings | 8/10/2026 8:30:00 AM |
As of Aug 14 2026, 1:04 PM, AkshayaAI assigns APGE (Apogee Therapeutics Inc) a Strong signal. The composite (RMTPGV) score and full factor breakdown are available to signed-in members.
APGE's RSI is overbought (RSI 76). A reading above 70 is typically considered overbought and below 30 oversold.
APGE is trading about 0% below its 52-week high and 280% above its 52-week low as of Aug 14 2026, 1:04 PM.
APGE's next earnings date is 8/10/2026 8:30:00 AM.
APGE is classified under Healthcare-Genetherapy in AkshayaAI's taxonomy.
AkshayaAI provides AI-generated, informational stock analytics for US and India markets. This is not personalized investment advice. Figures are as of Aug 14 2026, 1:04 PM and may not reflect real-time prices. Always do your own research.
Instant, data-backed answers — free to try.